Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eddy Roosnek

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|July 6, 2016
T-bet and Eomesodermin in NK Cell Development, Maturation, and FunctionFederico Simonetta, Amandine Pradier, Eddy Roosnek
Transplant Immunology|September 10, 2002
Selection of unrelated bone marrow donors by serology, molecular typing and cellular assaysJean-Marie Tiercy, Jean Villard, Eddy Roosnek
Trends in Immunology|September 11, 2007
HLA and KIR polymorphisms affect NK-cell anti-tumor activityJakob R Passweg, Bertrand Huard, Jean-Marie Tiercy, et al.
Blood|April 4, 2002
Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clonesChristoph Schaniel, Marie Gottar, Eddy Roosnek, et al.
European Journal of Immunology|November 19, 2004
Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacityLionel Arlettaz, Sylvie Degermann, Casimir De Rham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II studyYves Chalandon, Eddy Roosnek, Bernadette Mermillod, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2015
NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and EomesoderminFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Frontiers in Immunology|September 9, 2016
Modulation of T-bet and Eomes during Maturation of Peripheral Blood NK Cells Does Not Depend on Licensing/Educating KIRAmandine Pradier, Federico Simonetta, Sophie Waldvogel, et al.
Arthritis and Rheumatism|October 2, 2007
Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosisYann Parel, Michel Aurrand-Lions, Agneta Scheja, et al.
European Journal of Immunology|November 2, 2004
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytesLionel Arlettaz, Jean Villard, Casimir de Rham, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|July 6, 2016
T-bet and Eomesodermin in NK Cell Development, Maturation, and FunctionFederico Simonetta, Amandine Pradier, Eddy Roosnek
Transplant Immunology|September 10, 2002
Selection of unrelated bone marrow donors by serology, molecular typing and cellular assaysJean-Marie Tiercy, Jean Villard, Eddy Roosnek
Trends in Immunology|September 11, 2007
HLA and KIR polymorphisms affect NK-cell anti-tumor activityJakob R Passweg, Bertrand Huard, Jean-Marie Tiercy, et al.
Blood|April 4, 2002
Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clonesChristoph Schaniel, Marie Gottar, Eddy Roosnek, et al.
European Journal of Immunology|November 19, 2004
Expression of inhibitory KIR is confined to CD8+ effector T cells and limits their proliferative capacityLionel Arlettaz, Sylvie Degermann, Casimir De Rham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II studyYves Chalandon, Eddy Roosnek, Bernadette Mermillod, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2015
NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and EomesoderminFederico Simonetta, Amandine Pradier, Carine Bosshard, et al.
Frontiers in Immunology|September 9, 2016
Modulation of T-bet and Eomes during Maturation of Peripheral Blood NK Cells Does Not Depend on Licensing/Educating KIRAmandine Pradier, Federico Simonetta, Sophie Waldvogel, et al.
Arthritis and Rheumatism|October 2, 2007
Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosisYann Parel, Michel Aurrand-Lions, Agneta Scheja, et al.
European Journal of Immunology|November 2, 2004
Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytesLionel Arlettaz, Jean Villard, Casimir de Rham, et al.
Pageof 4